Impact of dose and volume on the tolerance of central nervous system

Rays - International Journal of Radiological Sciences

Volumn 30, Issue 2, 2005, Pages 189-195

  Balducci, Mario ^a   Mattiucci, Gian Carlo ^a   Dinapoli, Nicola ^a   Bavasso, Antonella ^a   De Renzi, Filippo ^a   Marazzi, Fabio ^a   Maronta, Daniela ^a   Deodato, Francesco ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Nervous central system; Radiotherapy; Tolerance

Indexed keywords

BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN TUMOR; CANCER CONTROL; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; HUMAN; QUALITY OF LIFE; RADIATION NECROSIS; SHORT SURVEY; TOXICITY TESTING; TREATMENT OUTCOME;

CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; QUALITY OF LIFE; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 27744477113     PISSN: 03907740     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (35)

1. LAPIERRE N, ZURAW L, CAIRNCROSS G. Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 2002; 64: 259-273.
2. KARIM AB, AFRA D, CORNU P et al. Randomized trial on the efficacy of radiotherapy for cerebral low grade glioma in the adult: European organization for research and treatment of cancer study 22845 with medical research council study BRO4: an interim analysis. In J Radiot Oncol Biol Phys 2002; 52: 316-324.
3. TRAUTMANN TG, SHAW EG. Supratentorial low grade glioma: is there a role for radiation therapy? Ann Acad Med Singapore. 1996; 25: 392-396.
4. FISCHER A, HOLFELDER H. Lokales amyloid im gehirn. Deutsche Zeitschrift fur Chirurgie. 1930; 227: 475-483.
5. ARMSTRONG CL, GOLDSTEIN B, SHERA D, LEDAKIS GE, TALLENT EM. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. 2003 Cancer 2003; 97: 649-656.
6. MEYERS CA, HESS KR. Multifaceted end-points in brain tumor clinical trials: Cognitive deterioration precedes MRI progression. Neuro-Oncology 2003; 5: 89-95.
7. ARMSTRONG CL, GYATO K, AWADALLA AW et al. A critical review of the clinical effects of therapeutic irradiation damage to the brain: the roots of controversy. Neuropsyc Review 2004; 14: 65-85.
8. WANG GJ VOLKOW ND, LAU YH, FOWLER JS et al. Glucose metabolic changes in nontumoral brain tissue of patients with brain tumour following radiotherapy: a preliminary study. J Comput Assist Tomogr 1996; 20: 709-714.
9. ARMSTRONG CL, RUFFER JE, CORN BW, DE VRIES K, MOLLMAN JE. Biphasic patterns of memory deficits following moderate dose/partial brain irradiation: Neuropsychologic outcome and proposed mechanisms. J Clin Oncol 1996; 13: 2263-2271.
10. ARMSTRONG CL, CORN BW, RUFFER JE, PRUITT AA, MOLLMAN JE, PHILLIPS PC. Radiotherapeutic effects on brain function: Double dissociation of memory systems. 2000; Neuropsychiatry Neuropsychol Behav Neurol 2000; 13: 101-111.
11. ARMSTRONG CL, STERN CH, RUFFER J, CORN B. Memory performance used to detect radiation effects on cognitive functioning. Appl Neuropsychol 2001; 8: 129-139.
12. GOLDSTEIN B, ARMSTRONG CL, MODETINO E, LEDAKIS GE, JOHN C, HUNTER JV. Picture and word recognition memory in adult intracranial tumor patients. Brain Cogn 2004; 54: 1-6.
13. MONJE ML, MIZUMATSU S, FIKE JR, PALMER TD. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002; 8: 955-962.
14. HAMPSTEAD BM, GUGLIELMI L, ARMSTRONG CL. Early delay hippocampal MTR change in patients with low grade primary brain tumors [Abstract]. Arch Clin Neuropsychol 2003; 18: 770-771.
15. PAPADOPOULOS MC, SAADOUN S, DAVIES DC, BELL BA. Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg 2001; 15: 101-108.
16. SCHNEIDER BF, EBERHARD DA, STEINER LE. Histopathology of arteriovenous malformations after gamma knife radiosurgery. J Neurosurg 1997; 87: 352-357.
17. GIGLIO P, GILBERT MR. Cerebral radiation necrosis. Neurologist 2003; 9: 180-188.
18. CORN BW, YOUSEM DM, SCOTT CB et al. White matter changes are correlated significantly with radiation dose. 1994; Cancer 1994; 74: 2828-2835.
19. SPUNBERG JJ, CHANG CH, GOLDMAN M, AURICCHIO E, BELL JJ. Quality of long-term survival following irradiation for intracranial tumors in children under the age of two. J. Radiat Oncol Biol Phys 1981; 7: 727-736.
20. OMURA M, AIDA N, SEKIDO K, KAKEHI M, MATSUBARA S. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: Clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 38: 241-249.
21. LONGEWAY K, MULHERN R, CRISCO J et al. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific toCNSrelapse and therapy. 1990; Am J Pediatr Hematol Oncol 1990; 12: 45-50.
22. MULHERN RK, FAIRCLOUGH D, OCHS D. A prospective comparison of neuropsychological performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation. J Clin Oncol 1991; 9: 1348-1356.
23. OCHS J, MULHERN R, FAIRCLOUGH D et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity in long-term survivors of childhood leukemia given cranial radiation or parenteral methotrexate: A prospective study. J Clin Oncol 1991; 9: 145-151.
24. RUBENSTEIN CL, VARNI JW, KATZ ER. Cognitive functioning in long-term survivors of childhood leukemia: A prospective analysis. J Dev Behav Pediatr 1990; 11: 301-305.
25. TUCKER J, PRIOR PF, GREEN CR et al. Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma. 1989; Br J Cancer 1989; 60: 775-780.
26. HOPPE-HIRSCH E, RENIER D, LELLOUCH-TUBIANA A, SAINTE-ROSE C, PIERRE-KAHN A, HIRSCH JF. Medulloblastoma in childhood: Progressive intellectual deterioration. Childs Nerv Syst 1990; 6: 60-65.
27. RIVA D, PANTALEONI C, MILANI N, BELANI FF. Impairment of neuropsychological functions in children with medulloblastomas and astrocytomas in the posterior fossa. Childs Nerv Syst 1989; 5: 107-110.
28. SILVERMAN CL, PALKES H, TALENT B, KOVANAR E, CLOUSE JW, THOMAS PR. Late effects of radiotherapy of patients with cerebellar medulloblastoma. Cancer 1984; 54: 825-829.
29. LAUKKANEN E, KLONOFF H, ALLAN B, GRAEB D, MURRAY N. The role of prophylactic brain irradiation in limited stage small cell lung cancer: Clinical, neuropsychologic, and CT sequelae. 1988; Int J Radiat Oncol Biol Phys 1988; 14: 1109-1117.
30. AL-AMRO A, AND SCHULTZ H. Moyamoya vasculopathy after cranial irradiation - A case Report. Acta Oncol 1995; 34: 261-263.
31. CORN BW, YOUMSEN DM, SCOTT CB et al. White matter changes are correlated significantly with radiation dose. Cancer 1994; 74: 2828-2835.
32. SCALLIET P, LANDUYT W, VAN DER SCHUEREN E. Repair kinetics as a determining factor for late tolerance of central nervous system to low dose rate irradiation. Radiother Oncol 1989; 14: 345-353.
33. MULHERN RK, KEPNER JL, THOMAS PR, ARMSTRONG FD, FRIEDMAN HS, KUN LE. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: A Pediatric Oncology Group study. 1998; J Clin Oncol 1998; 16: 1723-1728.
34. SLOAN AE, ARNOLD SM, ST CLAIR WH, REGINE WF. Brain injury: current management and investigations. Semin Radiat Oncol 2003; 13: 309-321.
35. LEE AWM, KWONG DL, LEUNG S et al. Factors affecting risk of symptomatic temporal lobe necrosis: Significance of fractional dose and treatment time. Int J Radiat Oncol Biol Phys 2002; 53: 75-85.